127 related articles for article (PubMed ID: 23976904)
1. The prognostic role of cancer stem cells in breast tumors.
Bonito MD; Cantile M; Malzone G; Liguori G; Botti G
J Clin Med Res; 2013 Oct; 5(5):325-6. PubMed ID: 23976904
[No Abstract] [Full Text] [Related]
2.
Xia P
Stem Cell Investig; 2017; 4():87. PubMed ID: 29270413
[TBL] [Abstract][Full Text] [Related]
3. CD133 in Breast Cancer Cells: More than a Stem Cell Marker.
Brugnoli F; Grassilli S; Al-Qassab Y; Capitani S; Bertagnolo V
J Oncol; 2019; 2019():7512632. PubMed ID: 31636668
[TBL] [Abstract][Full Text] [Related]
4. BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer.
Dionísio MR; Vieira AF; Carvalho R; Conde I; Oliveira M; Gomes M; Pinto MT; Pereira P; Pimentel J; Souza C; Marques MMC; Duval da Silva V; Barroso A; Preto D; Cameselle-Teijeiro JF; Schmitt F; Ribeiro AS; Paredes J
Cells; 2020 Nov; 9(11):. PubMed ID: 33182375
[TBL] [Abstract][Full Text] [Related]
5. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
Rocha RL; Hilsenbeck SG; Jackson JG; Lee AV; Figueroa JA; Yee D
J Natl Cancer Inst; 1996 May; 88(9):601-6. PubMed ID: 8609661
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
[TBL] [Abstract][Full Text] [Related]
7. ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer.
Panigoro SS; Kurnia D; Kurnia A; Haryono SJ; Albar ZA
Int J Surg Oncol; 2020; 2020():7863243. PubMed ID: 32695508
[TBL] [Abstract][Full Text] [Related]
8. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
9. Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.
Pece S; Disalvatore D; Tosoni D; Vecchi M; Confalonieri S; Bertalot G; Viale G; Colleoni M; Veronesi P; Galimberti V; Di Fiore PP
EBioMedicine; 2019 Apr; 42():352-362. PubMed ID: 30846393
[TBL] [Abstract][Full Text] [Related]
10. Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis.
Schwede M; Spentzos D; Bentink S; Hofmann O; Haibe-Kains B; Harrington D; Quackenbush J; Culhane AC
PLoS One; 2013; 8(3):e57799. PubMed ID: 23536770
[TBL] [Abstract][Full Text] [Related]
11. "Stem cell like" breast cancers-a model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1.
Rody A; Karn T; Holtrich U; Kaufmann M
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):11-5. PubMed ID: 18417270
[TBL] [Abstract][Full Text] [Related]
12. The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors.
Cabuk D; Yetimoglu E; Simsek T; Gacar G; Subasi C; Canturk Z; Ercin C; Karaoz E; Uygun K
J BUON; 2016; 21(5):1121-1128. PubMed ID: 27837613
[TBL] [Abstract][Full Text] [Related]
13. The Role of Breast Cancer Stem Cell-Related Biomarkers as Prognostic Factors.
Ko CCH; Chia WK; Selvarajah GT; Cheah YK; Wong YP; Tan GC
Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32961774
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.
O'Conor CJ; Chen T; González I; Cao D; Peng Y
Biomark Med; 2018 Jul; 12(7):813-820. PubMed ID: 29902924
[TBL] [Abstract][Full Text] [Related]
15. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
16. Identification of single chain antibodies to breast cancer stem cells using phage display.
Gur D; Liu S; Shukla A; Pero SC; Wicha MS; Krag DN
Biotechnol Prog; 2009; 25(6):1780-7. PubMed ID: 19899107
[TBL] [Abstract][Full Text] [Related]
17. The Role of Serotonin in Breast Cancer Stem Cells.
Gwynne WD; Shakeel MS; Girgis-Gabardo A; Hassell JA
Molecules; 2021 May; 26(11):. PubMed ID: 34073226
[TBL] [Abstract][Full Text] [Related]
18. Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells.
Altundag K; Altundag O; Elkiran ET; Cengiz M; Ozisik Y
Med Hypotheses; 2004; 63(1):56-8. PubMed ID: 15193347
[TBL] [Abstract][Full Text] [Related]
19. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
20. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]